Pre-op videos may ease recovery for cancer patients: study

Share this article:
Pre-op videos may ease recovery for cancer patients: study
Pre-op videos may ease recovery for cancer patients: study

What-to-expect videos were associated with lower rates of pain and increased surgery satisfaction, according to a study that focused on cancer patients. Published in the May issue of Journal of the American College of Surgeons, the study focused on those with late-stage lung cancer, a group with a 4% survival rate. A cohort of 270 surgery candidates were placed into two groups: one, which received the standard consult and pamphlets about the operation, and a second, which was given a 30-minute video that explained how to prepare for surgery, the surgery itself, recovery and pain management.

The video also advised patients to keep exercising until the day of surgery and to remain active once they got home. “We wanted patients to be able to take some ownership and not completely feel that they were handing themselves over to someone else,” Traves Crabtree, the study lead, said in a statement.

The second group was not required to watch the video but also received printed materials and the typical doctor consult.

The results: patients who did not watch the video ranked pain at about 1.34 when they left the hospital. Patients who watched the video averaged a lower pain score -- about 0.98. And video-free patients rated their surgical satisfaction at around 1.85, lower than the average 2.14 ranking among those who watched the 30-minute preparatory video.

Crabtree said the study isn't permission for surgeons to use the video in place of patient interaction, but it does offer insight into how doctors and patients prioritize information differently. The video helps fill in conversational gaps.

“What's important to us as surgeons might not be a primary issue to the patient. We might say, ‘Here's how the operation goes, and here's your risk of dying [without it].' But the patient might actually want to know how they will get around two weeks or two months from now,” he said.

The study's results were used to create a patient education kit called “Your Lung Operation.”
Share this article:

Email Newsletters

More in News

Sanofi expands Gaucher disease portfolio

Sanofi expands Gaucher disease portfolio

The oral medication Cerdelga joins Cerezyme in its Fabry disease arsenal. Sanofi expects the drug will be priced "on par" with Cerezyme, which goes for around $300,000 a year in ...

Amicus seeks to upset Fabry market

Amicus seeks to upset Fabry market

Phase-III tests indicate patients may be able to switch from injectable enzyme-replacement therapies, like Fabrazyme, to the firm's oral drug.

Five things for pharma marketers to know: Wednesday, August 20

Five things for pharma marketers to know: Wednesday, ...

Novartis explores the virtual care space, a court has dismissed a lawsuit against IPAB, Doctors Without Borders calls the Ebola outbreak "a complete disaster" and Pfizer becomes the first pharma ...